Alex Denner, Sarissa Capital Management (photo credit: Andrew Harrer/Bloomberg) Sarissa Capital Management’s chief investment officer Alexander Denner knows very well that specializing in drug, biotech and other health care stocks can
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.